HHS cancels funding for Moderna bird flu vaccine
Digest more
The Health and Human Services Department, led by vaccine skeptic Robert F. Kennedy Jr., has canceled $766 million in payments to develop a vaccine against pandemic flu viruses.
Moderna isn’t giving up on the combo shot entirely—it plans to resubmit later this year after it collects more data from its Phase III trials, which test how well a new treatment works compared to existing options.
Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) seeking approval for its COVID-19 and Influenza combination vaccine for adults aged 50 years and older.
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy.
A combination shot for flu and Covid-19 using messenger RNA generated antibodies in a study, but US government regulators want to see data on whether the new vaccine protects people from getting sick.